Return to search

Raymond James adds new managing director to team

Prior to joining Raymond James, Kaeding worked at at Piper Sandler.

Raymond James has hired Ryan Kaeding as managing director. Prior to joining Raymond James, Kaeding worked at at Piper Sandler.


ST. PETERSBURG, Fla. ─ Raymond James has expanded its capabilities in health care investment banking with the hiring of Ryan Kaeding as managing director, deepening the firm’s expertise in the medical technology sector. Kaeding joins a growing Los Angeles team, where he will focus on the medical devices space.

“Ryan is a talented and knowledgeable professional who has deep experience working with clients that are established, rapidly growing, market-leading platforms in the med tech space,” said Andrew Gitkin, co-head of Health Care Investment Banking. “His experience will align nicely with the types of companies we center our business around.”

Kaeding has over 15 years of health care transaction experience and joins Raymond James after nine years at Piper Sandler, focused on med tech investment banking. At Piper Sandler, Kaeding completed over 65 med tech transactions, spanning sell-side and buy-side M&A, IPOs, public and private financings, structured financings, divestitures, spin-offs, converts and debt financings. Previously, Kaeding worked at St. Jude Medical in business development for the cardiovascular division and began his career as a CPA at Deloitte.

“I’m pleased to join the well-respected health care practice at Raymond James,” said Kaeding. “Medical devices is a rapidly evolving industry with cutting-edge technologies and innovative products that impact patients across the globe. It is critical that our clients have access to the capital and support to continue growing their businesses and maximize their potential.”

In the last two years, Raymond James has made nine senior hires across Investment Banking, Equity Research, Sales & Trading and Equity Capital Markets that work as one team to serve middle-market health care clients in the biotechnology, medical technology, health care services and health care technology sectors.

About Raymond James Investment Banking
Raymond James Investment Banking offers highly regarded capital formation and financial advisory services. Since 2015, we have participated in raising nearly $300 billion in capital for our corporate clients and completed over 925 advisory assignments, including nearly 800 M&A buy-side or sell-side advisory assignments as of 3/31/2021. © 2021 Raymond James & Associates, Inc., member New York Stock Exchange/SIPC.

About Raymond James Financial, Inc.
Raymond James Financial, Inc. (NYSE: RJF) is a leading diversified financial services company providing private client group, capital markets, asset management, banking and other services to individuals, corporations and municipalities. The company has approximately 8,300 financial advisors. Total client assets are $1.13 trillion. Public since 1983, the firm is listed on the New York Stock Exchange under the symbol RJF. Additional information is available at